• BlackRock raised its voting rights attached to shares in ChemoMetec to 15.02% on Nov. 6, 2026, crossing the 15% threshold.
• The Nov. 11 disclosure put voting rights through financial instruments at 0.22%, bringing total voting rights to 15.24%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ChemoMetec A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611111245OMX_____CNEWS_EN_GNW1001303123_en) on November 11, 2026, and is solely responsible for the information contained therein.